Vitality Watch

Dossier clinicaltrials trial early 01-jul-2026
Small or early-phase human trial or pilot study

A Scalable Nutrition Adherence Intervention

Key claim: Investigators hypothesize that a scalable adherence program will achieve high adherence to Mediterranean and modified Mediterranean-ketogenic diets and that these diets will improve gut–brain axis markers of Alzheimer’s pathogenesis more in adults with mild cognitive impairment than in cognitively normal older adults.

Abstract

Objective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida.

The investigators hypothesize that:

1. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., good adherence) in the Modified Mediterranean-Ketogenic diet (MMKD) group and an average score of >6 on the MEDAS questionnaire in the Mediterranean group during the 10-week program. Further, we hypothesize that the use of ongoing monthly support groups will bolster long-term adherence.

Objective 2: To evaluate the effects of adherence to Mediterranean versus MMKD on novel gut-brain axis markers of Alzheimer’s disease pathogenesis in individuals with mild cognitive impairment compared to cognitively normal older adults.

The investigators hypothesize that individuals with mild cognitive impairment will:

  1. Have greater evidence of gut dysbiosis at baseline than cognitively normal controls and
  2. Will demonstrate greater increases in beneficial gut microbial metabolites in response to adherence to Mediterranean-Ketogenic nutrition and the Mediterranean diet compared to CN controls.

Why this matters

Investigators hypothesize that a scalable adherence program will achieve high adherence to Mediterranean and modified Mediterranean-ketogenic diets and that these diets will improve gut–brain axis markers of Alzheimer’s pathogenesis more in adults with mild cognitive impairment than in cognitively normal older adults.

Source

Link

Briefing card

A Scalable Nutrition Adherence Intervention
Stage: trial early · clinicaltrials · 01-jul-2026

Investigators hypothesize that a scalable adherence program will achieve high adherence to Mediterranean and modified Mediterranean-ketogenic diets and that these diets will improve gut–brain axis markers of Alzheimer’s pathogenesis more in adults with mild cognitive impairment than in cognitively normal older adults.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06121986

build build 880 · 2bcef25 · 2026-11-18